Sort by
Refine Your Search
-
Listed
-
Country
-
Employer
- ;
- RMIT University
- ; University of Southampton
- University of Oslo
- ; University of Hertfordshire
- ; University of Warwick
- Academic Europe
- CK-CARE AG
- Christine Kühne – Center for Allergy Research and Education (CK-CARE)
- Heidelberg University
- Ilya Pharma
- Johannes Gutenberg University Mainz •
- Karolinska Institutet
- Leibniz
- Leiden University Medical Center (LUMC)
- Linköping University
- Radboud University Medical Center (Radboudumc)
- Stockholm University
- TRON – Translationale Oncology Oncology at the University Medical Center of the Johannes Gutenberg University Mainz •
- Technical University of Munich
- University Medical Centre Groningen (UMCG)
- University of Basel
- iBET - Instituto de Biologia Experimental e Tecnológica
- 13 more »
- « less
-
Field
-
to study how the immune system can be harnessed to develop cancer immunotherapies. In particular, we are studying how oncolytic virotherapy can be used in synergy with immunotherapy to achieve optimal
-
such as radio-immunotherapy. Image analysis, programming and use of clinical software’s for treatment planning will be central components of the work. The project will concern both photon and particle
-
unknown chemokine can be used when developing next generation immunotherapies. Requirements Research FieldMedical sciencesEducation LevelMaster Degree or equivalent Skills/Qualifications Profile We
-
biomarkers for precise disease monitoring. Furthermore, the unique glycan profiles of tumors provide appealing targets for cancer immunotherapy. This project seeks to exploit tumor-specific glycosylation
-
such as immunotherapies are revolutionising cancer treatment. However, as they are not effective in all patients they should be tailored to the right patients while work to identify new drug targets and
-
lipids, offering potential tumor biomarkers for precise disease monitoring. Furthermore, the unique glycan profiles of tumors provide appealing targets for cancer immunotherapy. This project seeks
-
Specific Requirements - You are a highly motivated candidate with an interest in immunotherapy and metabolism. - You have an MSc in Biomedical Sciences, Pharmaceutical Sciences, Biochemistry or a related
-
at the Department of Biomedicine (“Cancer Immunology”) and PD Dr. Matter at the Department of Pathology are seeking a highly motivated PhD candidate with scientific interest in Cancer Immunology & Immunotherapy
-
position within a Research Infrastructure? No Offer Description The LIT - Leibniz Institute for Immunotherapy (foundation under civil law) (www.lit.eu ) is a biomedical research center focusing on
-
The LIT - Leibniz Institute for Immunotherapy (foundation under civil law) (www.lit.eu ) is a biomedical research center focusing on translational immunology in the fields of cancer immunotherapy